Cel Sci CORP DEF 14A proxy statements

CEL-SCI Corporation has issued a Notice of Annual Meeting of Shareholders to be held on August 14, 2026, detailing proposals including director elections, stock plan approvals, executive compensation votes, and auditor ratification.

CEL-SCI Corporation is holding its annual shareholder meeting on May 19, 2025, to vote on key proposals including the election of directors, adoption of new stock option and bonus plans, a potential reverse stock split, and ratification of the company's auditor.

CEL-SCI has identified a target patient population for its Multikine cancer therapy and is advancing regulatory filings after overcoming manufacturing challenges.

CEL-SCI Corporation announces its annual shareholder meeting to be held on April 19, 2024, including proposals to elect directors, adopt a new stock option plan, and ratify the appointment of its independent accounting firm.